Purpose: Pentoxifylline (PTX) and tocopherol (Vitamin E) are antioxidants previously shown to be useful in combination in the treatment of late radiation induced toxicity. The purpose of this study was to investigate the benefit of combination therapy with carbogen pentoxifylline and tocopherol in the mitigation of late radiation effects. As the optimal duration of PTX and tocopherol treatment has not been fully established, we studied short versus extended treatment duration.
Methods: We conducted a phase II prospective randomised study of short versus prolonged treatment with pentoxifylline (800 mg) and tocopherol (1000 IU) orally once daily in patients with grade 3 toxicity post radical radiotherapy. In addition, all 18 patients received inhaled carbogen (95% oxygen + 5% CO2) over 90 minutes, 5 days per, week for 3 weeks. The primary endpoint was improvement in maximum Lent-Soma toxicity scores.
Results: Maximum Lent-Soma scores improved in six of the eighteen patients (response rate 33%). The proportion of patients responding to treatment in the prolonged treatment arm B was more than double than in the shorter arm A, but this did not reach statistical significance (p 0.321). Two patients who had prolonged treatment (arm B) had complete resolution of their symptoms which was maintained at 2 and 3 years follow up.
Conclusions: We recommend prolonged treatment for 12 months, with PTX and tocopherol in combination with carbogen therapy, in the management of late radiation effects.
Further information:
Related posts:
- Acute radiation dermatitis in breast cancer: topical therapy with vitamin E acetate in lipophilic gel base
- Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer – a prospective pilot study
- Does LigaSure(TM) reduce fluid drainage in axillary dissection? A randomised prospective clinical trial
- Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
- Homeopathic treatment of elderly patients – a prospective observational study with follow-up over a two year period
Posted in